SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Laura M. Bystrom, Stefano Rivella, Cancer cells with irons in the fire, Free Radical Biology and Medicine, 2014,

    CrossRef

  2. You have free access to this content2
    Paul Martin, Andrea DiMartini, Sandy Feng, Robert Brown, Michael Fallon, Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation, Hepatology, 2014, 59, 3
  3. 3
    Shinya Toyokuni, Iron and thiols as two major players in carcinogenesis: friends or foes?, Frontiers in Pharmacology, 2014, 5,

    CrossRef

  4. 4
    Klaus Schümann, Thomas Ettle, Bernadett Szegner, Bernd Elsenhans, Noel W. Solomons, Risiken und Nutzen der Eisensupplementation: Empfehlungen zur Eisenaufnahme kritisch betrachtet, Perspectives in Medicine, 2014, 2, 1-4, 19

    CrossRef

  5. You have free access to this content5
    Silvia Fargion, Luca Valenti, Anna Ludovica Fracanzani, Role of iron in hepatocellular carcinoma, Clinical Liver Disease, 2014, 3, 5
  6. 6
    Linda Björkhem-Bergman, Magnus Backheden, Karin Söderberg Löfdal, Statin treatment reduces the risk of hepatocellular carcinoma but not colon cancer—results from a nationwide case-control study in Sweden, Pharmacoepidemiology and Drug Safety, 2014, 23, 9
  7. 7
    Covadonga Huidobro, Estela G. Toraño, Agustín F. Fernández, Rocío G. Urdinguio, Ramón M. Rodríguez, Cecilia Ferrero, Pablo Martínez-Camblor, Loreto Boix, Jordi Bruix, Juan Luís García-Rodríguez, Marta Varela-Rey, José María Mato, María Luz Martínez-Chantar, Mario F. Fraga, A DNA methylation signature associated with the epigenetic repression of glycine N-methyltransferase in human hepatocellular carcinoma, Journal of Molecular Medicine, 2013, 91, 8, 939

    CrossRef

  8. 8
    Iván Lyra-González, Laura Esther Flores-Fong, Ignacio González-García, David Medina-Preciado, Juan Armendáriz-Borunda, Adenoviral gene therapy in hepatocellular carcinoma: a review, Hepatology International, 2013, 7, 1, 48

    CrossRef

  9. 9
    Pushpjeet Kanwar, Kris V Kowdley, Diagnosis and treatment of hereditary hemochromatosis: an update, Expert Review of Gastroenterology & Hepatology, 2013, 7, 6, 517

    CrossRef

  10. 10
    Melanie Bruegel, Daniela Muenzel, Simone Waldt, Katja Specht, Ernst J. Rummeny, Hepatic angiosarcoma: cross-sectional imaging findings in seven patients with emphasis on dynamic contrast-enhanced and diffusion-weighted MRI, Abdominal Imaging, 2013, 38, 4, 745

    CrossRef

  11. 11
    Albert J. Czaja, Hepatocellular Carcinoma and Other Malignancies in Autoimmune Hepatitis, Digestive Diseases and Sciences, 2013, 58, 6, 1459

    CrossRef

  12. 12
    Suzy V. Torti, Frank M. Torti, Iron and cancer: more ore to be mined, Nature Reviews Cancer, 2013, 13, 5, 342

    CrossRef

  13. 13
    Emad H. Asham, Ahmed Kaseb, R. Mark Ghobrial, Management of Hepatocellular Carcinoma, Surgical Clinics of North America, 2013, 93, 6, 1423

    CrossRef

  14. 14
    Angelica M. Merlot, Danuta S. Kalinowski, Des R. Richardson, Novel Chelators for Cancer Treatment: Where Are We Now?, Antioxidants & Redox Signaling, 2013, 18, 8, 973

    CrossRef

  15. 15
    Aruljothi Subramaniam, Muthu K. Shanmugam, Ekambaram Perumal, Feng Li, Alamelu Nachiyappan, Xiaoyun Dai, Shivananju Nanjunda Swamy, Kwang Seok Ahn, Alan Prem Kumar, Benny K.H. Tan, Kam Man Hui, Gautam Sethi, Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2013, 1835, 1, 46

    CrossRef

  16. 16
    Arch G. Mainous, Robert U. Wright, Mary M. Hulihan, Waleed O. Twal, Christine E. McLaren, Vanessa A. Diaz, Gordon D. McLaren, W. Scott Argraves, Althea M. Grant, Telomere length and elevated iron: The influence of phenotype and HFE genotype, American Journal of Hematology, 2013, 88, 6
  17. 17
    Aiko Kida, George B. McDonald, Gastrointestinal, Hepatobiliary, Pancreatic, and Iron-Related Diseases in Long-Term Survivors of Allogeneic Hematopoietic Cell Transplantation, Seminars in Hematology, 2012, 49, 1, 43

    CrossRef

  18. You have free access to this content18
    A. Siddique, K. V. Kowdley, Review article: the iron overload syndromes, Alimentary Pharmacology & Therapeutics, 2012, 35, 8
  19. 19
    Cristina Della Corte, Massimo Colombo, Surveillance for Hepatocellular Carcinoma, Seminars in Oncology, 2012, 39, 4, 384

    CrossRef

  20. 20
    Alan C. Paterson, Antonello Pietrangelo, MacSween's Pathology of the Liver, 2012,

    CrossRef

  21. 21
    Silvia Fargion, Luca Valenti, Anna Ludovica Fracanzani, Beyond hereditary hemochromatosis: New insights into the relationship between iron overload and chronic liver diseases, Digestive and Liver Disease, 2011, 43, 2, 89

    CrossRef

  22. 22
    Mark G. O'Doherty, Marie M. Cantwell, Liam J. Murray, Lesley A. Anderson, Christian C. Abnet, Dietary fat and meat intakes and risk of reflux esophagitis, Barrett's esophagus and esophageal adenocarcinoma, International Journal of Cancer, 2011, 129, 6
  23. 23
    Ashraf Haddad, Gopal C. Kowdley, Timothy M. Pawlik, Steven C. Cunningham, Hereditary Pancreatic and Hepatobiliary Cancers, International Journal of Surgical Oncology, 2011, 2011, 1

    CrossRef

  24. 24
    Katarzyna Sikorska, Tomasz Romanowski, Piotr Stalke, Ewa Iżycka-Świeszewska, Krzysztof Piotr Bielawski, Iron overload and HFE gene mutations in Polish patients with liver cirrhosis, Hepatobiliary & Pancreatic Diseases International, 2011, 10, 3, 270

    CrossRef

  25. 25
    Michael L. Nieder, George B. McDonald, Aiko Kida, Sangeeta Hingorani, Saro H. Armenian, Kenneth R. Cooke, Michael A. Pulsipher, K. Scott Baker, National Cancer Institute–National Heart, Lung and Blood Institute/Pediatric Blood and Marrow Transplant Consortium First International Consensus Conference on Late Effects After Pediatric Hematopoietic Cell Transplantation: Long-Term Organ Damage and Dysfunction, Biology of Blood and Marrow Transplantation, 2011, 17, 11, 1573

    CrossRef

  26. 26
    Maximus V. Peto, Aluminium and Iron in Humans: Bioaccumulation, Pathology, and Removal, Rejuvenation Research, 2010, 13, 5, 589

    CrossRef

  27. 27
    Silvia Fargion, Luca Valenti, Anna Ludovica Fracanzani, Hemochromatosis gene (HFE) mutations and cancer risk: Expanding the clinical manifestations of hereditary iron overload, Hepatology, 2010, 51, 4
  28. 28
    Anna Ludovica Fracanzani, Alberto Piperno, Luca Valenti, Mirella Fraquelli, Sabina Coletti, Alessandra Maraschi, Dario Consonni, Enzo Coviello, Dario Conte, Silvia Fargion, Hemochromatosis in Italy in the last 30 years: Role of genetic and acquired factors, Hepatology, 2010, 51, 2
  29. 29
    Augusto Villanueva, Pippa Newell, Yujin Hoshida, Inherited hepatocellular carcinoma, Best Practice & Research Clinical Gastroenterology, 2010, 24, 5, 725

    CrossRef

  30. 30
    Mark G. O’Doherty, Christian C. Abnet, Liam J. Murray, Jayne V. Woodside, Lesley A. Anderson, John D. Brockman, Marie M. Cantwell, Iron intake and markers of iron status and risk of Barrett’s esophagus and esophageal adenocarcinoma, Cancer Causes & Control, 2010, 21, 12, 2269

    CrossRef

  31. 31
    Paola Dongiovanni, Anna Ludovica Fracanzani, Gaetano Cairo, Chiara Paola Megazzini, Stefano Gatti, Raffaela Rametta, Silvia Fargion, Luca Valenti, Iron-Dependent Regulation of MDM2 Influences p53 Activity and Hepatic Carcinogenesis, The American Journal of Pathology, 2010, 176, 2, 1006

    CrossRef

  32. 32
    Juwon Lim, Soyeun Kim, Soshin Ke, Belong Cho, The Association Chronic Liver Diseases with Health Related Behaviors in South Korea, Korean Journal of Family Medicine, 2010, 31, 4, 302

    CrossRef

  33. 33
    Michael C. Kew, Hepatic iron overload and hepatocellular carcinoma, Cancer Letters, 2009, 286, 1, 38

    CrossRef

  34. 34
    Faisal S Dar, Walid Faraj, Muhammad B Zaman, Adam Bartlett, Adrian Bomford, Adrian O’Sullivan, John O’Grady, Michael Heneghan, Mohamed Rela, Nigel D Heaton, Outcome of liver transplantation in hereditary hemochromatosis, Transplant International, 2009, 22, 7
  35. 35
    Douglas A. Corley, Ai Kubo, T. R. Levin, Gladys Block, Laurel Habel, Gregory J. Rumore, Charles Quesenberry, Patricia Buffler, Hemochromatosis Gene Status as a Risk Factor for Barrett’s Esophagus, Digestive Diseases and Sciences, 2008, 53, 12, 3095

    CrossRef

  36. 36
    Denise Rizzolo, Mona M. Sedrak, Hereditary hemochromatosis: Iron overload as an indicator of disease, Journal of the American Academy of Physician Assistants, 2008, 21, 10, 18

    CrossRef

  37. 37
    Douglas A. Corley, Ai Kubo, Theodore R. Levin, Laurel Habel, Wei Zhao, Patricia Leighton, Gregory Rumore, Charles Quesenberry, Patricia Buffler, Gladys Block, Iron Intake and Body Iron Stores as Risk Factors for Barrett's Esophagus: A Community-Based Study, The American Journal of Gastroenterology, 2008, 103, 12, 2997

    CrossRef

  38. 38
    Ri-Sheng Yu, Ying Chen, Biao Jiang, Liu-Hong Wang, Xiu-Fang Xu, Primary hepatic sarcomas: CT findings, European Radiology, 2008, 18, 10, 2196

    CrossRef

  39. 39
    Annika Kau, Johannes Vermehren, Christoph Sarrazin, Treatment predictors of a sustained virologic response in hepatitis B and C, Journal of Hepatology, 2008, 49, 4, 634

    CrossRef

  40. 40
    Michael C. Kew, George A. Asare, Dietary iron overload in the African and hepatocellular carcinoma, Liver International, 2007, 27, 6
  41. 41
    Eeva Juvonen, Leila Sahlstedt, Jaakko Parkkinen, Tapani Ruutu, Inhibition of erythroid and granulocyte-macrophage colony formation by non-transferrin-bound iron in vitro: protective effect of apotransferrin, European Journal of Haematology, 2007, 79, 2
  42. 42
    Klaus Schümann, Thomas Ettle, Bernadett Szegner, Bernd Elsenhans, Noel W. Solomons, On risks and benefits of iron supplementation recommendations for iron intake revisited, Journal of Trace Elements in Medicine and Biology, 2007, 21, 3, 147

    CrossRef

  43. 43
    Morris Sherman, Screening for hepatocellular carcinoma, Hepatology Research, 2007, 37,
  44. 44
    Morris Sherman, Surveillance for Hepatocellular Carcinoma and Early Diagnosis, Clinics in Liver Disease, 2007, 11, 4, 817

    CrossRef

  45. 45
    Jean-Claude Trinchet, Nathalie Ganne-Carrié, Faut-il dépister le carcinome hépatocellulaire ?, Gastroentérologie Clinique et Biologique, 2006, 30, 6-7, 880

    CrossRef

  46. 46
    George A. Asare, Kensese S. Mossanda, Michael C. Kew, Alan C. Paterson, Christina P. Kahler-Venter, Kwanele Siziba, Hepatocellular carcinoma caused by iron overload: A possible mechanism of direct hepatocarcinogenicity, Toxicology, 2006, 219, 1-3, 41

    CrossRef

  47. 47
    Manfred Nairz, Günter Weiss, Molecular and clinical aspects of iron homeostasis: from anemia to hemochromatosis, Wiener klinische Wochenschrift, 2006, 118, 15-16, 442

    CrossRef

  48. 48
    Anna Ludovica Fracanzani, Silvia Fargion, Maria Antonietta Stazi, Luca Valenti, Pietro Amoroso, Elisabetta Cariani, Angelo Sangiovanni, Maurizio Tommasini, Angelo Rossini, Cristina Bertelli, Erika Fatta, Valeria Patriarca, Sonia Brescianini, Tomaso Stroffolini, Association between heterozygosity for HFE gene mutations and hepatitis viruses in hepatocellular carcinoma, Blood Cells, Molecules, and Diseases, 2005, 35, 1, 27

    CrossRef

  49. 49
    A. Kalt, A. Wagner, S. Zeuzem, W. Tilgen, J. Reichrath, Generalisierte Hyperpigmentierung und Acanthosis nigricans maligna bei einem Patienten mit hereditärer Hämochromatose und Magenkarzinom, Der Hautarzt, 2005, 56, 6, 581

    CrossRef

  50. 50
    A. T. Chan, J. Ma, G. J. Tranah, E. L. Giovannucci, N. Rifai, D. J. Hunter, C. S. Fuchs, Hemochromatosis Gene Mutations, Body Iron Stores, Dietary Iron, and Risk of Colorectal Adenoma in Women, JNCI Journal of the National Cancer Institute, 2005, 97, 12, 917

    CrossRef

  51. 51
    D. Maluf, A. Cotterell, B. Clark, T. Stravitz, H.M. Kauffman, R.A. Fisher, Hepatic Angiosarcoma and Liver Transplantation: Case Report and Literature Review, Transplantation Proceedings, 2005, 37, 5, 2195

    CrossRef

  52. 52
    M Tevfik Dorak, Alan K Burnett, Mark Worwood, HFE gene mutations in susceptibility to childhood leukemia: HuGE review, Genetics in Medicine, 2005, 7, 3, 159

    CrossRef

  53. 53
    Jordi Bruix, Morris Sherman, Management of hepatocellular carcinoma, Hepatology, 2005, 42, 5
  54. 54
    Stephen A. Harrison, Bruce R. Bacon, Relation of hemochromatosis with hepatocellular carcinoma: epidemiology, natural history, pathophysiology, screening, treatment, and prevention, Medical Clinics of North America, 2005, 89, 2, 391

    CrossRef

  55. 55
    Z. DYER, K. PELTEKIAN, S. VELDHUYZEN VAN ZANTEN, Review article: the changing epidemiology of hepatocellular carcinoma in Canada, Alimentary Pharmacology & Therapeutics, 2005, 22, 1
  56. 56
    Morris Sherman, Screening for hepatocellular carcinoma, Best Practice & Research Clinical Gastroenterology, 2005, 19, 1, 101

    CrossRef

  57. 57
    D. Das, Cancer and hereditary haemochromatosis, QJM, 2004, 97, 10, 698

    CrossRef

  58. 58
    Laurie Blendis, Morris Sherman, Hepatocellular Carcinoma, American Journal of Cancer, 2004, 3, 6, 349

    CrossRef

  59. 59
    Giovanna Fattovich, Tommaso Stroffolini, Irene Zagni, Francesco Donato, Hepatocellular carcinoma in cirrhosis: Incidence and risk factors, Gastroenterology, 2004, 127, 5, S35

    CrossRef

  60. 60
    Kris V. Kowdley, Iron, hemochromatosis, and hepatocellular carcinoma, Gastroenterology, 2004, 127, 5, S79

    CrossRef

  61. 61
    Morris Sherman, Pathogenesis and screening for hepatocellular carcinoma, Clinics in Liver Disease, 2004, 8, 2, 419

    CrossRef

  62. 62
    Morris Sherman, Yuji Takayama, Screening and treatment for hepatocellular carcinoma, Gastroenterology Clinics of North America, 2004, 33, 3, 671

    CrossRef

  63. 63
    Maria Elmberg, Rolf Hultcrantz, Anders Ekbom, Lena Brandt, Sigvard Olsson, Rolf Olsson, Stefan Lindgren, Lars Lööf, Per Stål, Sven Wallerstedt, Sven Almer, Hanna Sandberg-Gertzén, Johan Askling, Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives, Gastroenterology, 2003, 125, 6, 1733

    CrossRef

  64. 64
    Marie Ann Bailey, Elizabeth M Brunt, Hepatocellular carcinoma: predisposing conditions and precursor lesions, Hematology/Oncology Clinics of North America, 2003, 17, 2, 625

    CrossRef

  65. 65
    Yves Deugnier, Iron and liver cancer, Alcohol, 2003, 30, 2, 145

    CrossRef

  66. 66
    George N. Ioannou, Kris V. Kowdley, Iron, HFE mutations, and hepatocellular carcinoma: is hepatic iron a carcinogen?, Clinical Gastroenterology and Hepatology, 2003, 1, 4, 246

    CrossRef

  67. 67
    Gérard Chalès, Pascal Guggenbuhl, Quand et comment dépister une hémochromatose génétique ?, Revue du Rhumatisme, 2003, 70, 7, 573

    CrossRef

  68. 68
    Gérard Chalès, Pascal Guggenbuhl, When and how should we screen for hereditary hemochromatosis?, Joint Bone Spine, 2003, 70, 4, 263

    CrossRef

  69. 69
    Paul Terry, Harri Vainio, Alicja Wolk, Elisabete Weiderpass, Dietary Factors in Relation to Endometrial Cancer: A Nationwide Case-Control Study in Sweden, Nutrition and Cancer, 2002, 42, 1, 25

    CrossRef

  70. 70
    M. Tevfik Dorak, Alan K. Burnett, Mark Worwood, Hemochromatosis Gene in Leukemia and Lymphoma, Leukemia & Lymphoma, 2002, 43, 3, 467

    CrossRef

  71. 71
    Mary Ann Huang, Jorge A. Marrero, Hepatocellular carcinoma, Current Opinion in Gastroenterology, 2002, 18, 3, 345

    CrossRef

  72. 72
    Marie Ann Bailey, Elizabeth M Brunt, Hepatocellular carcinoma: predisposing conditions and precursor lesions, Gastroenterology Clinics of North America, 2002, 31, 2, 641

    CrossRef

  73. 73
    G. Weiss, Iron and immunity: a double-edged sword, European Journal of Clinical Investigation, 2002, 32,
  74. 74
    Jurgen Fuchs, M. Podda, L. Packer, R. Kaufmann, Morbidity risk in HFE associated hereditary hemochromatosis C282Y heterozygotes, Toxicology, 2002, 180, 2, 169

    CrossRef

  75. 75
    Giovanna Fabio, Marina Zarantonello, Cristina Mocellin, Paola Bonara, Chiara Corengia, Silvia Fargion, Gemino Fiorelli, Peripheral lymphocytes and intracellular cytokines in C282Y homozygous hemochromatosis patients, Journal of Hepatology, 2002, 37, 6, 753

    CrossRef

  76. 76
    Takashi Koyama, Joel G. Fletcher, C. Daniel Johnson, Mark S. Kuo, Kenji Notohara, Lawrence J. Burgart, Primary Hepatic Angiosarcoma: Findings at CT and MR Imaging1, Radiology, 2002, 222, 3, 667

    CrossRef

  77. 77
    Thomas Ettle, Bernd Elsenhans, Klaus Schümann, Eisen,
  78. 78
    Gary C. Kanel, Liver, Gallbladder, and Extrahepatic Bile Ducts, The Cancer Handbook,